General Neurology
Botulinum toxin treatment of neurologic disorders
Mar. 06, 2024
Khashayar Dashtipour MD PhD
Associate Professor Neurology & Basic Sciences
Director, Division of Movement Disorders
Department of Neurology/Movement Disorders
Loma Linda University School of Medicine
Contributor Disclosures
Dr. Dashtipour of Loma Linda University School of Medicine received honorariums as consultant and speaker from Acadia, Acorda, Adamas, Allergan, Ipsen, Lundbeck, Merz, Neurocrine, Teva, and US World Meds..